| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| NKGen Biotech Inc. | Troculeucel (SNK01) | Mild-stage Alzheimer's disease | Phase 2a | Ongoing | Intravenous | Neurology |
| NLS Pharmaceutics Ltd. | Sanorex (mazindol) | Obesity | NDA Filing | oral | Endocrinology | |
| NLS Pharmaceutics Ltd. | Quilience (Mazindol ER) - (AMAZE) | Narcolepsy | Phase 3 | Oral | Neurology | |
| NLS Pharmaceutics Ltd. | Nolazol | ADHD | Phase 2 | Oral | Psychiatric | |
| NLS Pharmaceutics Ltd. | Quilience(R) - (POLARIS) | Narcolepsy | Phase 2a | Oral | Neurology | |
| Northwest Biotherapeutics Inc | DCVax-L | Glioblastoma multiforme (GBM) | Phase 3 | intralesional | Oncology | |
| Notable Labs Ltd. | VB-111 | Recurrent glioblastoma (rGBM) cancer | Phase 3 | Intravenous | Oncology | |
| Notable Labs Ltd. | Ofranergene obadenovec (VB-111) - (OVAL) | Recurrent platinum resistant ovarian cancer | Phase 3 | Intravenous | Oncology |